Intensive versus Conventional Glucose Control in Critically Ill Patients

被引:3278
作者
Finfer, S. [20 ]
Blair, D.
Bellomo, R. [4 ]
McArthur, C. [2 ]
Mitchell, I. [8 ]
Myburgh, J. [21 ]
Norton, R.
Potter, J. [20 ]
Chittock, D. [44 ]
Dhingra, V.
Foster, D.
Cook, D. [37 ]
Dodek, P. [39 ]
Hebert, P.
Henderson, W.
Heyland, D.
McDonald, E. [37 ]
Ronco, J.
Schweitzer, L.
Peto, R.
Sandercock, P.
Sprung, C.
Young, J. D.
Su, S. [1 ]
Heritier, S. [1 ]
Li, Q. [1 ]
Bompoint, S. [1 ]
Billot, L. [1 ]
Crampton, L. [1 ]
Darcy, F. [1 ]
Jayne, K. [1 ]
Kumarasinghe, V. [1 ]
Little, L. [1 ,25 ]
McEvoy, S. [1 ]
MacMahon, S. [1 ]
Pandey, S. [1 ]
Ryan, S. [1 ]
Shukla, R. [1 ]
Vijayan, B. [1 ]
Atherton, S. [2 ]
Bell, J. [2 ]
Hadfield, L. [2 ]
Hourigan, C. [2 ]
McArthur, C. [2 ]
Newby, L. [2 ]
Simmonds, C. [2 ]
Buhr, H. [3 ]
Eccleston, M. [3 ]
McGuinness, S. [3 ]
Parke, R. [3 ]
机构
[1] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia
[2] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand
[3] Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand
[4] Austin Hosp, Melbourne, Vic 3084, Australia
[5] Ballarat Base Hosp, Ballarat, Vic, Australia
[6] Blacktown Hosp, Blacktown, NSW, Australia
[7] Box Hill Hosp, Box Hill, Vic, Australia
[8] Canberra Hosp, Canberra, ACT, Australia
[9] Concord Repatriat Gen Hosp, Concord, NSW, Australia
[10] Fremantle Hosp, Fremantle, WA, Australia
[11] John Hunter Hosp, Newcastle, NSW, Australia
[12] Liverpool Hosp, Liverpool, NSW, Australia
[13] Middlemore Hosp, Auckland 6, New Zealand
[14] Nepean Hosp, Nepean, NSW, Australia
[15] N Shore Hosp, Auckland, New Zealand
[16] Prince Wales Hosp, Sydney, NSW, Australia
[17] Queen Elizabeth Hosp, Adelaide, SA, Australia
[18] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia
[19] Royal Hobart Hosp, Hobart, Tas, Australia
[20] Royal N Shore Hosp, Sydney, NSW, Australia
[21] St George Hosp, Sydney, NSW, Australia
[22] St Vincents Hosp, Melbourne, Vic, Australia
[23] Sir Charles Gairdner Hosp, Perth, WA, Australia
[24] Wellington Hosp, Wellington, New Zealand
[25] Western Hosp, Melbourne, Vic, Australia
[26] Wollongong Hosp, Wollongong, NSW, Australia
[27] NSW Inst Trauma & Injury Management, Sydney, NSW, Australia
[28] Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia
[29] Univ Sydney, Fac Med, Kolling Inst, Sydney, NSW 2006, Australia
[30] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW, Australia
[31] Calgary Hlth Reg, Calgary, AB, Canada
[32] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada
[33] Maisonneuve Rosemont Hosp, Montreal, PQ, Canada
[34] Mayo Clin, Rochester, MN USA
[35] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[36] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada
[37] St Josephs Healthcare, Hamilton, ON, Canada
[38] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[39] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[40] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[41] Toronto Gen Hosp, Toronto, ON, Canada
[42] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[43] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada
[44] Vancouver Gen Hosp, Vancouver, BC, Canada
[45] Vancouver Isl Hlth Author, Victoria, BC, Canada
基金
英国医学研究理事会;
关键词
TIGHT GLYCEMIC CONTROL; INSULIN THERAPY; MYOCARDIAL-INFARCTION; STRESS HYPERGLYCEMIA; DIABETIC-PATIENTS; BLOOD-GLUCOSE; CARE UNITS; MORTALITY; MANAGEMENT;
D O I
10.1056/NEJMoa0810625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The optimal target range for blood glucose in critically ill patients remains unclear. Methods Within 24 hours after admission to an intensive care unit (ICU), adults who were expected to require treatment in the ICU on 3 or more consecutive days were randomly assigned to undergo either intensive glucose control, with a target blood glucose range of 81 to 108 mg per deciliter (4.5 to 6.0 mmol per liter), or conventional glucose control, with a target of 180 mg or less per deciliter (10.0 mmol or less per liter). We defined the primary end point as death from any cause within 90 days after randomization. Results Of the 6104 patients who underwent randomization, 3054 were assigned to undergo intensive control and 3050 to undergo conventional control; data with regard to the primary outcome at day 90 were available for 3010 and 3012 patients, respectively. The two groups had similar characteristics at baseline. A total of 829 patients (27.5%) in the intensive-control group and 751 (24.9%) in the conventional-control group died (odds ratio for intensive control, 1.14; 95% confidence interval, 1.02 to 1.28; P = 0.02). The treatment effect did not differ significantly between operative (surgical) patients and nonoperative (medical) patients (odds ratio for death in the intensive-control group, 1.31 and 1.07, respectively; P = 0.10). Severe hypoglycemia (blood glucose level, = 40 mg per deciliter [2.2 mmol per liter]) was reported in 206 of 3016 patients (6.8%) in the intensive-control group and 15 of 3014 (0.5%) in the conventional-control group (P<0.001). There was no significant difference between the two treatment groups in the median number of days in the ICU (P = 0.84) or hospital (P = 0.86) or the median number of days of mechanical ventilation (P = 0.56) or renal-replacement therapy (P = 0.39). Conclusions In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg per deciliter. (ClinicalTrials.gov number, NCT00220987.)
引用
收藏
页码:1283 / 1297
页数:15
相关论文
共 37 条
  • [1] Standards of medical care in diabetes 2008
    不详
    [J]. DIABETES CARE, 2008, 31 : S12 - S54
  • [2] Intensive insulin therapy in critical illness - When is the evidence enough?
    Angus, DC
    Abraham, E
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (11) : 1358 - 1359
  • [3] Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control
    Aragon, Daleen
    [J]. AMERICAN JOURNAL OF CRITICAL CARE, 2006, 15 (04) : 370 - 377
  • [4] Glycemic control in the intensive care unit: Why we should wait for NICE-SUGAR
    Bellomo, R
    Egi, M
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (12) : 1546 - 1548
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] Intensive insulin therapy and pentastarch resuscitation in severe sepsis
    Brunkhorst, Frank M.
    Engel, Christoph
    Bloos, Frank
    Meier-Hellmann, Andreas
    Ragaller, Max
    Weiler, Norbert
    Moerer, Onnen
    Gruendling, Matthias
    Oppert, Michael
    Grond, Stefan
    Olthoff, Derk
    Jaschinski, Ulrich
    John, Stefan
    Rossaint, Rolf
    Welte, Tobias
    Schaefer, Martin
    Kern, Peter
    Kuhnt, Evelyn
    Kiehntopf, Michael
    Hartog, Christiane
    Natanson, Charles
    Loeffler, Markus
    Reinhart, Konrad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 125 - 139
  • [7] Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
    Capes, SE
    Hunt, D
    Malmberg, K
    Gerstein, HC
    [J]. LANCET, 2000, 355 (9206) : 773 - 778
  • [8] Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients - A systematic overview
    Capes, SE
    Hunt, D
    Malmberg, K
    Pathak, P
    Gerstein, HC
    [J]. STROKE, 2001, 32 (10) : 2426 - 2432
  • [9] Is there more to glycaemic control than meets the eye?
    Chase, J. Geoffrey
    Shaw, Geoffrey M.
    [J]. CRITICAL CARE, 2007, 11 (04):
  • [10] *CRIT CAR NUTR, 2007, US ENT NUTR VS PAR N